Anti-PD-1 Therapy Response Predicted by the Combination of Exosomal PD-L1 and CD28

Anti-PD-1 therapy has been approved for cancer treatment. However, the response rate is unsatisfactory. The expression of PD-L1 in tumor tissues is unreliable to predict the treatment response. Recent studies have suggested that exosomal PD-L1 not only exerts immunosuppressive effects but also plays...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Zhang, Chaoxu, Fan, Yibo, Che, Xiaofang, Zhang, Min, Li, Zhi, Li, Ce, Wang, Shuo, Wen, Ti, Hou, Kezuo, Shao, Xinye, Liu, Yunpeng, Qu, Xiujuan
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7266952/
https://ncbi.nlm.nih.gov/pubmed/32528882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00760
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados